Patents Assigned to GRAVITAS MEDICAL, INC.
-
Publication number: 20250009287Abstract: Devices and methods to measure gastric residual volume (GRV) are described where at least one additive component (a GRV indicator) may be dispersed in a body lumen such as a stomach. The GRV indicator may changes a physical (chemical, electrical, thermal, mechanical, optical, etc.) characteristic within the stomach by a measureable degree. This degree of change and/or the rate of return to the previous state, may be used to determine the GRV of a patient. The determined GRV can also be used to automatically or semi-automatically control the patient's feeding rate and/or volume and/or frequency to adequately nourish the patient but avoid complications. The physical characteristic(s) may also be used to detect that the feeding catheter or tube is in the correct location (ie stomach vs lung or esophagus.Type: ApplicationFiled: September 13, 2024Publication date: January 9, 2025Applicant: Gravitas Medical, Inc.Inventors: Daniel R. BURNETT, Marcie HAMILTON, Evan S. LUXON, Alexander VERGARA, Saheel SUTARIA
-
Patent number: 12109036Abstract: Devices and methods to measure gastric residual volume (GRV) are described where at least one additive component (a GRV indicator) may be dispersed in a body lumen such as a stomach. The GRV indicator may changes a physical (chemical, electrical, thermal, mechanical, optical, etc.) characteristic within the stomach by a measureable degree. This degree of change and/or the rate of return to the previous state, may be used to determine the GRV of a patient. The determined GRV can also be used to automatically or semi-automatically control the patient's feeding rate and/or volume and/or frequency to adequately nourish the patient but avoid complications. The physical characteristic(s) may also be used to detect that the feeding catheter or tube is in the correct location (ie stomach vs lung or esophagus.Type: GrantFiled: February 18, 2022Date of Patent: October 8, 2024Assignee: Gravitas Medical, Inc.Inventors: Daniel R. Burnett, Marcie Hamilton, Evan S. Luxon, Alexander Vergara, Saheel Sutaria
-
Publication number: 20240245583Abstract: Methods and apparatus for accessing and monitoring the gastrointestinal tract are disclosed where one variation of a feeding system may generally comprise a gastric access device having a length. One or more sensors may be positioned along the length, and a controller may be in communication with the one or more sensors. The controller may be configured to receive a signal from the one or more sensors relating to a parameter of a fluid within a stomach of a subject. Furthermore, the controller may be configured to determine a gastric residual volume (GRV) based upon the signal and control a rate of a feed or formula introduced into the stomach such that the GRV is maintained at a steady level.Type: ApplicationFiled: April 4, 2024Publication date: July 25, 2024Applicant: Gravitas Medical, Inc.Inventors: Saheel SUTARIA, Daniel R. BURNETT, Sam RADOCHONSKI
-
Publication number: 20240206758Abstract: Embodiments relate to guiding medical care based on detected gastric function. For example, gastric acid stimulant or suppressant is administered, and then a change in the gastric juice H+ concentration is measured. This change is compared to a guidance H+ concentration differential indicative of relatively healthy gastric function. Medical care is guided based on a relatively healthy gastric function if the measured H+ concentration differential is equal to or exceeds the guidance H+ concentration differential, while medical care is guided based on a relatively unhealthy gastric function if the measured H+ concentration differential is less than the guidance H+ concentration differential. Disclosed embodiments implementing this procedure include, but are not limited to, methods, apparatus, processors, computer programs, and computer-readable mediums.Type: ApplicationFiled: February 6, 2024Publication date: June 27, 2024Applicant: Gravitas Medical, Inc.Inventor: Elliott BENNETT-GUERRERO
-
Patent number: 11925450Abstract: Embodiments relate to guiding medical care based on detected gastric function. For example, gastric acid stimulant or suppressant is administered, and then a change in the gastric juice H+ concentration is measured. This change is compared to a guidance H+ concentration differential indicative of relatively healthy gastric function. Medical care is guided based on a relatively healthy gastric function if the measured H+ concentration differential is equal to or exceeds the guidance H+ concentration differential, while medical care is guided based on a relatively unhealthy gastric function if the measured H+ concentration differential is less than the guidance H+ concentration differential. Disclosed embodiments implementing this procedure include, but are not limited to, methods, apparatus, processors, computer programs, and computer-readable mediums.Type: GrantFiled: May 8, 2020Date of Patent: March 12, 2024Assignee: Gravitas Medical, Inc.Inventor: Elliott Bennett-Guerrero
-
Publication number: 20230181095Abstract: Methods and apparatus for guiding medical care based on sensor data from the gastrointestinal tract are described utilizing an apparatus which can be used with enteral feeding. Generally, the apparatus includes an elongated body having a length configured for insertion into a stomach and at least one pair of electrodes located along the length of the elongated body and positionable for placement within the stomach. A controller in electrical communication with the at least one pair of electrodes is included and the control may also be configured to measure a conductivity or impedance between the pair of electrodes and to determine a gastric residual volume of the stomach based on the measured conductivity or impedance.Type: ApplicationFiled: February 9, 2023Publication date: June 15, 2023Applicant: Gravitas Medical, Inc.Inventors: Saheel SUTARIA, Elliott BENNETT-GUERRERO, Braden ELIASON, Arthur SPIVY, Daniel R. BURNETT
-
Publication number: 20220338794Abstract: Methods and apparatus for guiding medical care based on sensor data from the gastrointestinal tract are described utilizing an apparatus which can be used with enteral feeding. Generally, the apparatus includes an elongated body having a length configured for insertion into a stomach and at least one pair of electrodes located along the length of the elongated body and positionable for placement within the stomach. A controller in electrical communication with the at least one pair of electrodes is included and the control may also be configured to measure a conductivity or impedance between the pair of electrodes and to determine a gastric residual volume of the stomach based on the measured conductivity or impedance.Type: ApplicationFiled: July 1, 2022Publication date: October 27, 2022Applicant: Gravitas Medical, Inc.Inventors: Saheel SUTARIA, Eliott BENNETT-GUERRERO, Braden ELIASON, Arthur SPIVY, Daniel R. BURNETT
-
Publication number: 20220304898Abstract: Methods and apparatus for accessing and monitoring the gastrointestinal tract are described herein. One variation of a feeding tube system may generally comprise a gastric access device having a length, a controller in communication with the gastric access device, and one or more impedance or conductivity sensors positioned along the length and one or more temperature sensors positioned along the length. The controller may be configured to receive a first signal associated with the impedance or conductivity sensors and a second signal associated with respiration and determine whether a placement of the gastric access device is within a stomach of the subject.Type: ApplicationFiled: March 4, 2021Publication date: September 29, 2022Applicant: Gravitas Medical, Inc.Inventors: Saheel SUTARIA, Daniel R. BURNETT, Michael BAYCURA, David THOMPSON, Arthur SPIVY, Elliott BENNETT-GUERRERO, Sam RADOCHONSKI, Nicholas MERCER
-
Patent number: 11406320Abstract: Methods and apparatus for guiding medical care based on sensor data from the gastrointestinal tract are described utilizing an apparatus which can be used with enteral feeding. Generally, the apparatus includes an elongated body having a length configured for insertion into a stomach and at least one pair of electrodes located along the length of the elongated body and positionable for placement within the stomach. A controller in electrical communication with the at least one pair of electrodes is included and the control may also be configured to measure a conductivity or impedance between the pair of electrodes and to determine a gastric residual volume of the stomach based on the measured conductivity or impedance.Type: GrantFiled: November 13, 2017Date of Patent: August 9, 2022Assignee: Gravitas Medical, Inc.Inventors: Saheel Sutaria, Eliott Bennett-Guerrero, Braden Eliason, Arthur Spivy, Daniel R. Burnett
-
Publication number: 20220167910Abstract: Devices and methods to measure gastric residual volume (GRV) are described where at least one additive component (a GRV indicator) may be dispersed in a body lumen such as a stomach. The GRV indicator may changes a physical (chemical, electrical, thermal, mechanical, optical, etc.) characteristic within the stomach by a measureable degree. This degree of change and/or the rate of return to the previous state, may be used to determine the GRV of a patient. The determined GRV can also be used to automatically or semi-automatically control the patient's feeding rate and/or volume and/or frequency to adequately nourish the patient but avoid complications. The physical characteristic(s) may also be used to detect that the feeding catheter or tube is in the correct location (ie stomach vs lung or esophagus.Type: ApplicationFiled: February 18, 2022Publication date: June 2, 2022Applicant: Gravitas Medical, Inc.Inventors: Daniel R. BURNETT, Marcie HAMILTON, Evan S. LUXON, Alexander VERGARA, Saheel SUTARIA
-
Patent number: 11284832Abstract: Devices and methods to measure gastric residual volume (GRV) are described where at least one additive component (a GRV indicator) may be dispersed in a body lumen such as a stomach. The GRV indicator may changes a physical (chemical, electrical, thermal, mechanical, optical, etc.) characteristic within the stomach by a measureable degree. This degree of change and/or the rate of return to the previous state, may be used to determine the GRV of a patient. The determined GRV can also be used to automatically or semi-automatically control the patient's feeding rate and/or volume and/or frequency to adequately nourish the patient but avoid complications. The physical characteristic(s) may also be used to detect that the feeding catheter or tube is in the correct location (ie stomach vs lung or esophagus.Type: GrantFiled: July 28, 2016Date of Patent: March 29, 2022Assignee: Gravitas Medical, Inc.Inventors: Daniel R. Burnett, Marcie Hamilton, Evan S. Luxon, Alexander Vergara, Saheel Sutaria
-
Publication number: 20200268276Abstract: Embodiments relate to guiding medical care based on detected gastric function. For example, gastric acid stimulant or suppressant is administered, and then a change in the gastric juice H+ concentration is measured. This change is compared to a guidance H+ concentration differential indicative of relatively healthy gastric function. Medical care is guided based on a relatively healthy gastric function if the measured H+ concentration differential is equal to or exceeds the guidance H+ concentration differential, while medical care is guided based on a relatively unhealthy gastric function if the measured H+ concentration differential is less than the guidance H+ concentration differential. Disclosed embodiments implementing this procedure include, but are not limited to, methods, apparatus, processors, computer programs, and computer-readable mediums.Type: ApplicationFiled: May 8, 2020Publication date: August 27, 2020Applicant: Gravitas Medical, Inc.Inventor: Elliott BENNETT-GUERRERO
-
Patent number: 10687731Abstract: Embodiments relate to guiding medical care based on detected gastric function. For example, gastric acid stimulant or suppressant is administered, and then a change in the gastric juice H+ concentration is measured. This change is compared to a guidance H+ concentration differential indicative of relatively healthy gastric function. Medical care is guided based on a relatively healthy gastric function if the measured H+ concentration differential is equal to or exceeds the guidance H+ concentration differential, while medical care is guided based on a relatively unhealthy gastric function if the measured H+ concentration differential is less than the guidance H+ concentration differential. Disclosed embodiments implementing this procedure include, but are not limited to, methods, apparatus, processors, computer programs, and computer-readable mediums.Type: GrantFiled: November 23, 2016Date of Patent: June 23, 2020Assignee: Gravitas Medical, Inc.Inventor: Elliott Bennet-Guerrero
-
Publication number: 20180078195Abstract: Methods and apparatus for guiding medical care based on sensor data from the gastrointestinal tract are described utilizing an apparatus which can be used with enteral feeding. Generally, the apparatus includes an elongated body having a length configured for insertion into a stomach and at least one pair of electrodes located along the length of the elongated body and positionable for placement within the stomach. A controller in electrical communication with the at least one pair of electrodes is included and the control may also be configured to measure a conductivity or impedance between the pair of electrodes and to determine a gastric residual volume of the stomach based on the measured conductivity or impedance.Type: ApplicationFiled: November 13, 2017Publication date: March 22, 2018Applicant: Gravitas Medical, Inc.Inventors: Saheel SUTARIA, Eliott BENNETT-GUERRERO, Braden ELIASON, Arthur SPIVY, Daniel R. BURNETT
-
Patent number: 9532739Abstract: Embodiments relate to guiding medical care based on detected gastric function. For example, gastric acid stimulant or suppressant is administered, and then a change in the gastric juice H+ concentration is measured. This change is compared to a guidance H+ concentration differential indicative of relatively healthy gastric function. Medical care is guided based on a relatively healthy gastric function if the measured H+ concentration differential is equal to or exceeds the guidance H+ concentration differential, while medical care is guided based on a relatively unhealthy gastric function if the measured H+ concentration differential is less than the guidance H+ concentration differential. Disclosed embodiments implementing this procedure include, but are not limited to, methods, apparatus, processors, computer programs, and computer-readable mediums.Type: GrantFiled: June 13, 2012Date of Patent: January 3, 2017Assignee: GRAVITAS MEDICAL, INC.Inventor: Elliott Bennett-Guerrero